Provider Profile:
George Yoo, M.D., FACS

• Esophageal Cancer
• Laryngeal and Hypopharyngeal Cancer
• Melanoma
• Neck Cancer
• Nose Cancer
• Salivary Gland Cancer
• Sinus Cancer
• Skin Cancer
• Throat Cancer

School

• University of Kansas Medical Center - Kansas City, KS

Residency

• Otolaryngology, Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, MD

Fellowships

• Academic Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland

Awards

• 2010-2016, 2018-2019 Detroit's Top Doctors, Hour Magazine
• Voted one of Best Doctors Inc. 2011-2014
• Best Doctors of the Year 2010-2016

Professional Memberships

• American Academy of Otolaryngology-Head and Neck Surgery
• Radiation Therapy Oncology Group (Head and Neck Committee)
• American Society of Clinical Oncology
• Southwest Oncology Group (Board of Governors, Melanoma Committee, Chair, Surgical Committee and Gene Therapy Sub-committee)
• American College of Surgeons
• Michigan Otolaryngological Society 

• Fine Needle Aspiration of Head and Neck Masses in the Operating Room: Accuracy and Potential Benefits. Diag. Cytopath 36(6):369-374, 2008. Authors: Yousef N; Arabi MH; Feng J; Yoo GH; Al-Abbadi MA.
  
• Docetaxel Effects on the Surgical Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg, 134(7):735-742, 2008. Authors: Yoo GH; Subramanian G; Piechocki MP; Ensley JF; Tulunay OE; Lonardo F; Kim H; Won J; Stevens T; Lin HS.
  
• Craniocervical Necrotizing Fasciitis with and without Thoracic Extension-Management Strategies and Outcome. Am J Oto, 30(1):17-23, 2009. Authors: Mao JC; Carron MA; Fountain K; Stachler RJ; Yoo GH; Mathog RH; Coticchia JM;.
  
• A Phase II Trial of Surgery with Perioperative INGN 201 (Ad5CMV-p53) Gene Therapy Followed by Chemoradiotherapy for Advanced, Resectable Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx and Larynx: REPORT OF THE SOUTHWEST ONCOLOGY GROUP. Arch Otolaryngol Head Neck Surg, 135(9):869-874, 2009. Authors: Yoo GH; Moon J; Tsue T; Girod D; Kim H; Lonardo F; Wolf G; Valentino J; Hanna E; LeBlanc M; Ensley JF; Urba S.
  
• Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck. Clin Can Res 15(24):7719-7725, 2009. Authors: Nemunaitis J, Clayman G, Agarwala SS, Hrushesky W, Wells JR, Moore C, Hamm J, Yoo GH, Baselga J, Murphy BA, Menander KA, Licato LL, Chada S, Gibbons RD, Olivier M, Hainaut P, Roth JA, Sobol RE, Goodwin WJ.